LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 70 filers reported holding LARIMAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $317,100 | -59.2% | 70,000 | -62.8% | 0.02% | -63.6% |
| Q4 2022 | $776,428 | -31.7% | 187,997 | -47.0% | 0.07% | -25.0% |
| Q3 2022 | $1,136,000 | +132.8% | 354,928 | +42.7% | 0.09% | +158.8% |
| Q2 2022 | $488,000 | -51.8% | 248,800 | -0.5% | 0.03% | -37.0% |
| Q1 2022 | $1,013,000 | -63.4% | 250,000 | -2.6% | 0.05% | -47.1% |
| Q4 2021 | $2,769,000 | -6.4% | 256,620 | 0.0% | 0.10% | -11.3% |
| Q3 2021 | $2,959,000 | +17.4% | 256,620 | 0.0% | 0.12% | +32.2% |
| Q2 2021 | $2,520,000 | -21.6% | 256,620 | +16.6% | 0.09% | -48.8% |
| Q1 2021 | $3,216,000 | -31.8% | 220,136 | 0.0% | 0.17% | -23.8% |
| Q4 2020 | $4,713,000 | +41.2% | 220,136 | 0.0% | 0.22% | -9.0% |
| Q3 2020 | $3,339,000 | +18.0% | 220,136 | 0.0% | 0.24% | +8.4% |
| Q2 2020 | $2,829,000 | – | 220,136 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,746,265 | $12,440,580 | 3.30% |
| Opaleye Management Inc. | 1,401,000 | $6,346,530 | 1.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $76,744,347 | 1.71% |
| GREAT POINT PARTNERS LLC | 900,000 | $4,077,000 | 0.80% |
| DAFNA Capital Management LLC | 236,873 | $1,073,035 | 0.32% |
| Perceptive Advisors | 2,280,709 | $10,331,612 | 0.30% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,323,594 | 0.28% |
| MANGROVE PARTNERS IM, LLC | 805,815 | $3,650,342 | 0.24% |
| Verition Fund Management LLC | 1,938,822 | $8,782,864 | 0.12% |
| Woodline Partners LP | 1,681,913 | $7,619,066 | 0.10% |